HUTCHMED (China) Limited
HCM
$17.93
$1.569.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,663.32% | 1,663.32% | 117.60% | 117.60% | -84.69% |
| Total Depreciation and Amortization | -2.14% | -2.14% | 38.54% | 38.54% | 64.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2,146.03% | -2,146.03% | -25.58% | -25.58% | -225.27% |
| Change in Net Operating Assets | -4.67% | -4.67% | -211.27% | -211.27% | -183.24% |
| Cash from Operations | -83.00% | -83.00% | 664.44% | 664.44% | -117.59% |
| Capital Expenditure | 8.32% | 8.32% | 5.19% | 5.19% | 58.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 474.66% | 474.66% | -329.59% | -329.59% | 101.60% |
| Cash from Investing | 423.70% | 423.70% | -465.11% | -465.11% | 98.28% |
| Total Debt Issued | -2.89% | -2.89% | -28.51% | -28.51% | -63.05% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 382.46% | 382.46% | -86.08% | -86.08% | -78.45% |
| Repurchase of Common Stock | -- | -- | -- | -- | -297.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 88.97% |
| Cash from Financing | 128.63% | 128.63% | -95.58% | -95.58% | -658.52% |
| Foreign Exchange rate Adjustments | 251.69% | 251.69% | -1,932.18% | -1,932.18% | 72.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.70% | 45.70% | -182.51% | -182.51% | 11.79% |